메뉴 건너뛰기




Volumn , Issue , 2005, Pages 9-42

Tumor associated antigens

Author keywords

antigen; epitope; tumor association

Indexed keywords


EID: 84885848129     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-3623-X_2     Document Type: Chapter
Times cited : (1)

References (188)
  • 1
    • 0026322151 scopus 로고
    • A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
    • van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991;254(5038):1643-1647.
    • (1991) Science , vol.254 , Issue.5038 , pp. 1643-1647
    • Van Der Bruggen, P.1    Traversari, C.2    Chomez, P.3
  • 2
    • 0029125899 scopus 로고
    • A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma
    • Coulie PG, Lehmann F, Lethe B, et al. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA. 1995;92(17):7976-7980.
    • (1995) Proc Natl Acad Sci USA , vol.92 , Issue.17 , pp. 7976-7980
    • Coulie, P.G.1    Lehmann, F.2    Lethe, B.3
  • 3
    • 0029862690 scopus 로고    scopus 로고
    • Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen
    • Wang RF, Parkhurst MR, Kawakami Y, Robbins PF, Rosenberg SA. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J Exp Med. 1996;183(3):1131-1140.
    • (1996) J Exp Med , vol.183 , Issue.3 , pp. 1131-1140
    • Wang, R.F.1    Parkhurst, M.R.2    Kawakami, Y.3    Robbins, P.F.4    Rosenberg, S.A.5
  • 4
    • 0034671802 scopus 로고    scopus 로고
    • Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma
    • Rimoldi D, Rubio-Godoy V, Dutoit V, et al. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma. J Immunol. 2000;165(12):7253-7261.
    • (2000) J Immunol , vol.165 , Issue.12 , pp. 7253-7261
    • Rimoldi, D.1    Rubio-Godoy, V.2    Dutoit, V.3
  • 5
    • 0035878998 scopus 로고    scopus 로고
    • Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas
    • Jul 15
    • Hanada K, Perry-Lalley DM, Ohnmacht GA, Bettinotti MP, Yang JC. Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas. Cancer Res. Jul 15 2001;61(14):5511-5516.
    • (2001) Cancer Res , vol.61 , Issue.14 , pp. 5511-5516
    • Hanada, K.1    Perry-Lalley, D.M.2    Ohnmacht, G.A.3    Bettinotti, M.P.4    Yang, J.C.5
  • 6
    • 2142644458 scopus 로고    scopus 로고
    • An antigenic peptide produced by peptide splicing in the proteasome
    • Apr 23
    • Vigneron N, Stroobant V, Chapiro J, et al. An antigenic peptide produced by peptide splicing in the proteasome. Science. Apr 23 2004;304(5670):587-590.
    • (2004) Science , vol.304 , Issue.5670 , pp. 587-590
    • Vigneron, N.1    Stroobant, V.2    Chapiro, J.3
  • 7
    • 0033591429 scopus 로고    scopus 로고
    • Cloning genes encoding MHC class II-restricted antigens: Mutated CDC27 as a tumor antigen
    • Wang RF, Wang X, Atwood AC, Topalian SL, Rosenberg SA. Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. Science. 1999;284(5418):1351-1354.
    • (1999) Science , vol.284 , Issue.5418 , pp. 1351-1354
    • Wang, R.F.1    Wang, X.2    Atwood, A.C.3    Topalian, S.L.4    Rosenberg, S.A.5
  • 8
    • 0037013827 scopus 로고    scopus 로고
    • Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: Its role in extracellular matrix formation and tumor metastasis
    • Jun 3
    • Wang HY, Zhou J, Zhu K, Riker AI, Marincola FM, Wang RF. Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis. J Exp Med. Jun 3 2002;195(11):1397-1406.
    • (2002) J Exp Med , vol.195 , Issue.11 , pp. 1397-1406
    • Wang, H.Y.1    Zhou, J.2    Zhu, K.3    Riker, A.I.4    Marincola, F.M.5    Wang, R.F.6
  • 9
    • 0028924986 scopus 로고
    • Class II transactivator regulates the expression of multiple genes involved in antigen presentation
    • Chang CH, Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med. 1995;181(2):765-767.
    • (1995) J Exp Med , vol.181 , Issue.2 , pp. 765-767
    • Chang, C.H.1    Flavell, R.A.2
  • 10
    • 0034282516 scopus 로고    scopus 로고
    • Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules
    • Chiari R, Hames G, Stroobant V, et al. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules. Cancer Res. 2000;60(17):4855-4863.
    • (2000) Cancer Res , vol.60 , Issue.17 , pp. 4855-4863
    • Chiari, R.1    Hames, G.2    Stroobant, V.3
  • 11
    • 0142219890 scopus 로고    scopus 로고
    • Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes
    • Oct 15
    • Maccalli C, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes. Cancer Res. Oct 15 2003;63(20):6735-6743.
    • (2003) Cancer Res , vol.63 , Issue.20 , pp. 6735-6743
    • Maccalli, C.1    Li, Y.F.2    El-Gamil, M.3    Rosenberg, S.A.4    Robbins, P.F.5
  • 12
    • 0032533507 scopus 로고    scopus 로고
    • The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene
    • Hogan KT, Eisinger DP, Cupp SB, 3rd, et al. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene. Cancer Res. 1998;58(22):5144-5150.
    • (1998) Cancer Res , vol.58 , Issue.22 , pp. 5144-5150
    • Hogan, K.T.1    Eisinger, D.P.2    Cupp Iii., S.B.3
  • 13
    • 0028304337 scopus 로고
    • Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
    • Cox AL, Skipper J, Chen Y, et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science. 1994;264(5159):716-719.
    • (1994) Science , vol.264 , Issue.5159 , pp. 716-719
    • Cox, A.L.1    Skipper, J.2    Chen, Y.3
  • 14
    • 0033103147 scopus 로고    scopus 로고
    • Biochemical Identification of a Mutated Human Melanoma Antigen Recognized by CD4(+) T Cells
    • Pieper R, Christian RE, Gonzales MI, et al. Biochemical Identification of a Mutated Human Melanoma Antigen Recognized by CD4(+) T Cells. J Exp Med. 1999;189(5):757-766.
    • (1999) J Exp Med , vol.189 , Issue.5 , pp. 757-766
    • Pieper, R.1    Christian, R.E.2    Gonzales, M.I.3
  • 15
    • 12644276375 scopus 로고    scopus 로고
    • A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
    • Chen YT, Scanlan MJ, Sahin U, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA. 1997;94(5):1914-1918.
    • (1997) Proc Natl Acad Sci USA , vol.94 , Issue.5 , pp. 1914-1918
    • Chen, Y.T.1    Scanlan, M.J.2    Sahin, U.3
  • 16
    • 0037083354 scopus 로고    scopus 로고
    • Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma
    • Ayyoub M, Stevanovic S, Sahin U, et al. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma. J Immunol. 2002;168(4):1717-1722.
    • (2002) J Immunol , vol.168 , Issue.4 , pp. 1717-1722
    • Ayyoub, M.1    Stevanovic, S.2    Sahin, U.3
  • 17
    • 0028052724 scopus 로고
    • Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
    • Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol. 1994;152(1):163-175.
    • (1994) J Immunol , vol.152 , Issue.1 , pp. 163-175
    • Parker, K.C.1    Bednarek, M.A.2    Coligan, J.E.3
  • 19
    • 0027973079 scopus 로고
    • The relationship between class i binding affinity and immunogenicity of potential cytotoxic T cell epitopes
    • Sette A, Vitiello A, Reherman B, et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol. 1994;153(12):5586-5592.
    • (1994) J Immunol , vol.153 , Issue.12 , pp. 5586-5592
    • Sette, A.1    Vitiello, A.2    Reherman, B.3
  • 20
    • 0028316911 scopus 로고
    • Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
    • Apr 26
    • Kawakami Y, Eliyahu S, Delgado CH, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA. Apr 26 1994;91(9):3515-3519.
    • (1994) Proc Natl Acad Sci USA , vol.91 , Issue.9 , pp. 3515-3519
    • Kawakami, Y.1    Eliyahu, S.2    Delgado, C.H.3
  • 21
    • 0028303166 scopus 로고
    • A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas [see comments]
    • Coulie PG, Brichard V, Van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas [see comments]. J Exp Med. 1994;180(1):35-42.
    • (1994) J Exp Med , vol.180 , Issue.1 , pp. 35-42
    • Coulie, P.G.1    Brichard, V.2    Van Pel, A.3
  • 22
    • 0033949981 scopus 로고    scopus 로고
    • Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma
    • Kawakami Y, Dang N, Wang X, et al. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. J Immunother. 2000;23(1):17-27.
    • (2000) J Immunother , vol.23 , Issue.1 , pp. 17-27
    • Kawakami, Y.1    Dang, N.2    Wang, X.3
  • 23
    • 0032520084 scopus 로고    scopus 로고
    • Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
    • Valmori D, Fonteneau JF, Lizana CM, et al. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J Immunol. 1998;160(4):1750-1758.
    • (1998) J Immunol , vol.160 , Issue.4 , pp. 1750-1758
    • Valmori, D.1    Fonteneau, J.F.2    Lizana, C.M.3
  • 24
    • 0029743737 scopus 로고    scopus 로고
    • Phenotypic analysis of antigen-specific T lymphocytes
    • Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274(5284):94-96.
    • (1996) Science , vol.274 , Issue.5284 , pp. 94-96
    • Altman, J.D.1    Pah, M.2    Pjr, G.3
  • 25
    • 0032819985 scopus 로고    scopus 로고
    • High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
    • Pittet MJ, Valmori D, Dunbar PR, et al. High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med. 1999;190(5):705-715.
    • (1999) J Exp Med , vol.190 , Issue.5 , pp. 705-715
    • Pittet, M.J.1    Valmori, D.2    Dunbar, P.R.3
  • 26
    • 0345016358 scopus 로고    scopus 로고
    • Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes
    • Dec 1
    • Benlalam H, Linard B, Guilloux Y, et al. Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes. J Immunol. Dec 1 2003;171(11):6283-6289.
    • (2003) J Immunol , vol.171 , Issue.11 , pp. 6283-6289
    • Benlalam, H.1    Linard, B.2    Guilloux, Y.3
  • 27
    • 0032579240 scopus 로고    scopus 로고
    • Meyer zum Buschenfelde KH, Wolfel T. Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1
    • Schneider J, Brichard V, Boon T, Meyer zum Buschenfelde KH, Wolfel T. Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1. Int J Cancer. 1998;75(3):451-458.
    • (1998) Int J Cancer , vol.75 , Issue.3 , pp. 451-458
    • Schneider, J.1    Brichard, V.2    Boon, T.3
  • 28
    • 0028298174 scopus 로고
    • Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection
    • Jul 5
    • Kawakami Y, Eliyahu S, Delgado CH, et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA. Jul 5 1994;91(14):6458-6462.
    • (1994) Proc Natl Acad Sci USA , vol.91 , Issue.14 , pp. 6458-6462
    • Kawakami, Y.1    Eliyahu, S.2    Delgado, C.H.3
  • 29
    • 0030587077 scopus 로고    scopus 로고
    • Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues
    • Parkhurst MR, Salgaller ML, Southwood S, et al. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. J Immunol. 1996;157(6):2539-2548.
    • (1996) J Immunol , vol.157 , Issue.6 , pp. 2539-2548
    • Parkhurst, M.R.1    Salgaller, M.L.2    Southwood, S.3
  • 30
    • 0028347940 scopus 로고
    • Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
    • Wolfel T, Van Pel A, Brichard V, et al. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol. 1994;24(3):759-764.
    • (1994) Eur J Immunol , vol.24 , Issue.3 , pp. 759-764
    • Wolfel, T.1    Van Pel, A.2    Brichard, V.3
  • 31
    • 0001433072 scopus 로고    scopus 로고
    • An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
    • Skipper JC, Hendrickson RC, Gulden PH, et al. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med. 1996;183(2):527-534.
    • (1996) J Exp Med , vol.183 , Issue.2 , pp. 527-534
    • Skipper, J.C.1    Hendrickson, R.C.2    Gulden, P.H.3
  • 32
    • 0033572502 scopus 로고    scopus 로고
    • MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte [In Process Citation]
    • Nishimura MI, Avichezer D, Custer MC, et al. MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte [In Process Citation]. Cancer Res. 1999;59(24):6230-6238.
    • (1999) Cancer Res , vol.59 , Issue.24 , pp. 6230-6238
    • Nishimura, M.I.1    Avichezer, D.2    Custer, M.C.3
  • 33
    • 0034997840 scopus 로고    scopus 로고
    • Identification of a New Shared HLA-A2.1 Restricted Epitope from the Melanoma Antigen Tyrosinase
    • Riley JP, Rosenberg SA, Parkhurst MR. Identification of a New Shared HLA-A2.1 Restricted Epitope From the Melanoma Antigen Tyrosinase. J Immunother. 2001;24(3):212-220.
    • (2001) J Immunother , vol.24 , Issue.3 , pp. 212-220
    • Riley, J.P.1    Rosenberg, S.A.2    Parkhurst, M.R.3
  • 34
    • 0030472678 scopus 로고    scopus 로고
    • Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
    • Wang RF, Appella E, Kawakami Y, Kang X, Rosenberg SA. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med. 1996;184(6):2207-2216.
    • (1996) J Exp Med , vol.184 , Issue.6 , pp. 2207-2216
    • Wang, R.F.1    Appella, E.2    Kawakami, Y.3    Kang, X.4    Rosenberg, S.A.5
  • 35
    • 0033084014 scopus 로고    scopus 로고
    • Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens [In Process Citation]
    • Castelli C, Tarsini P, Mazzocchi A, et al. Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens [In Process Citation]. J Immunol. 1999;162(3):1739-1748.
    • (1999) J Immunol , vol.162 , Issue.3 , pp. 1739-1748
    • Castelli, C.1    Tarsini, P.2    Mazzocchi, A.3
  • 36
    • 0037309192 scopus 로고    scopus 로고
    • Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1
    • Feb 1
    • Touloukian CE, Leitner WW, Schnur RE, et al. Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1. J Immunol. Feb 1 2003;170(3):1579-1585.
    • (2003) J Immunol , vol.170 , Issue.3 , pp. 1579-1585
    • Touloukian, C.E.1    Leitner, W.W.2    Schnur, R.E.3
  • 37
    • 0035890576 scopus 로고    scopus 로고
    • Mining the melanosome for tumor vaccine targets: P polypeptide is a novel tumor-associated antigen
    • Touloukian CE, Leitner WW, Robbins PF, Rosenberg SA, Restifo NP. Mining the Melanosome for Tumor Vaccine Targets: P.polypeptide Is a Novel Tumor-associated Antigen. Cancer Res. 2001;61(22):8100-8104.
    • (2001) Cancer Res , vol.61 , Issue.22 , pp. 8100-8104
    • Touloukian, C.E.1    Leitner, W.W.2    Robbins, P.F.3    Rosenberg, S.A.4    Restifo, N.P.5
  • 38
    • 0028050181 scopus 로고
    • Structure, chromosomal localization, and expression of 12 genes of the MAGE family
    • De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics. 1994;40(5):360-369.
    • (1994) Immunogenetics , vol.40 , Issue.5 , pp. 360-369
    • De Plaen, E.1    Arden, K.2    Traversari, C.3
  • 39
    • 0027980103 scopus 로고
    • Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
    • Gaugler B, Van den Eynde B, van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med. 1994;179(3):921-930.
    • (1994) J Exp Med , vol.179 , Issue.3 , pp. 921-930
    • Gaugler, B.1    Van Den Eynde, B.2    Van Der Bruggen, P.3
  • 40
    • 0028607185 scopus 로고
    • A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3
    • van der Bruggen P, Bastin J, Gajewski T, et al. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol. 1994;24(12):3038-3043.
    • (1994) Eur J Immunol , vol.24 , Issue.12 , pp. 3038-3043
    • Van Der Bruggen, P.1    Bastin, J.2    Gajewski, T.3
  • 41
    • 0033559238 scopus 로고    scopus 로고
    • Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3
    • Valmori D, Gileadi U, Servis C, et al. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J Exp Med. 1999;189(6):895-906.
    • (1999) J Exp Med , vol.189 , Issue.6 , pp. 895-906
    • Valmori, D.1    Gileadi, U.2    Servis, C.3
  • 42
    • 2642683198 scopus 로고    scopus 로고
    • Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes
    • Jager E, Chen YT, Drijfhout JW, et al. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med. 1998;187(2):265-270.
    • (1998) J Exp Med , vol.187 , Issue.2 , pp. 265-270
    • Jager, E.1    Chen, Y.T.2    Drijfhout, J.W.3
  • 43
    • 0032186274 scopus 로고    scopus 로고
    • A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames
    • Wang RF, Johnston SL, Zeng G, Topalian SL, Schwartzentruber DJ, Rosenberg SA. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. J Immunol. 1998;161(7):3598-3606.
    • (1998) J Immunol , vol.161 , Issue.7 , pp. 3598-3606
    • Wang, R.F.1    Johnston, S.L.2    Zeng, G.3    Topalian, S.L.4    Schwartzentruber, D.J.5    Rosenberg, S.A.6
  • 44
    • 0033595632 scopus 로고    scopus 로고
    • Humoral immune responses of cancer patients against Cancer-Testis" antigen NY-ESO-1: Correlation with clinical events
    • Jager E, Stockert E, Zidianakis Z, et al. Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer. 1999;84(5):506-510.
    • (1999) Int J Cancer , vol.84 , Issue.5 , pp. 506-510
    • Jager, E.1    Stockert, E.2    Zidianakis, Z.3
  • 45
    • 0033168930 scopus 로고    scopus 로고
    • Characterization of the GAGE genes that are expressed in various human cancers and in normal testis
    • De Backer O, Arden KC, Boretti M, et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res. 1999;59(13):3157-3165.
    • (1999) Cancer Res , vol.59 , Issue.13 , pp. 3157-3165
    • De Backer, O.1    Arden, K.C.2    Boretti, M.3
  • 46
    • 0032555951 scopus 로고    scopus 로고
    • Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage
    • Lupetti R, Pisarra P, Verrecchia A, et al. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. J Exp Med. 1998;188(6):1005-1016.
    • (1998) J Exp Med , vol.188 , Issue.6 , pp. 1005-1016
    • Lupetti, R.1    Pisarra, P.2    Verrecchia, A.3
  • 47
    • 0029053749 scopus 로고
    • Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines
    • Fisk B, Blevins TL, Wharton JT, Ioannides CG. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J Exp Med. 1995;181(6):2109-2117.
    • (1995) J Exp Med , vol.181 , Issue.6 , pp. 2109-2117
    • Fisk, B.1    Blevins, T.L.2    Wharton, J.T.3    Ioannides, C.G.4
  • 48
    • 0033565301 scopus 로고    scopus 로고
    • Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas
    • Rongcun Y, Salazar-Onfray F, Charo J, et al. Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas. J Immunol. 1999;163(2):1037-1044.
    • (1999) J Immunol , vol.163 , Issue.2 , pp. 1037-1044
    • Rongcun, Y.1    Salazar-Onfray, F.2    Charo, J.3
  • 49
    • 0031937298 scopus 로고    scopus 로고
    • The multi-epitope approach for immunotherapy for cancer: Identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors
    • Kawashima I, Hudson SJ, Tsai V, et al. The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum Immunol. 1998;59(1):1-14.
    • (1998) Hum Immunol , vol.59 , Issue.1 , pp. 1-14
    • Kawashima, I.1    Hudson, S.J.2    Tsai, V.3
  • 50
    • 0032213456 scopus 로고    scopus 로고
    • Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors
    • Zaks TZ, Rosenberg SA. Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors. Cancer Res. 1998;58(21):4902-4908.
    • (1998) Cancer Res , vol.58 , Issue.21 , pp. 4902-4908
    • Zaks, T.Z.1    Rosenberg, S.A.2
  • 51
    • 0037307840 scopus 로고    scopus 로고
    • CD4(+) Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame
    • Feb 1
    • Slager EH, Borghi M, Van Der Minne CE, et al. CD4(+) Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame. J Immunol. Feb 1 2003;170(3):1490-1497.
    • (2003) J Immunol , vol.170 , Issue.3 , pp. 1490-1497
    • Slager, E.H.1    Borghi, M.2    Van Der Minne, C.E.3
  • 52
    • 0034812048 scopus 로고    scopus 로고
    • Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing
    • Ayyoub M, Migliaccio M, Guillaume P, et al. Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing. Eur J Immunol. 2001;31(9):2642-2651.
    • (2001) Eur J Immunol , vol.31 , Issue.9 , pp. 2642-2651
    • Ayyoub, M.1    Migliaccio, M.2    Guillaume, P.3
  • 53
    • 0032971227 scopus 로고    scopus 로고
    • Degradation of cell proteins and the generation of MHC class I-presented peptides
    • Rock KL, Goldberg AL. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol. 1999;17:739-779.
    • (1999) Annu Rev Immunol , vol.17 , pp. 739-779
    • Rock, K.L.1    Goldberg, A.L.2
  • 54
    • 1142269466 scopus 로고    scopus 로고
    • Immune recognition of a human renal cancer antigen through post-translational protein splicing
    • Jan 15
    • Hanada K, Yewdell JW, Yang JC. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature. Jan 15 2004;427(6971):252-256.
    • (2004) Nature , vol.427 , Issue.6971 , pp. 252-256
    • Hanada, K.1    Yewdell, J.W.2    Yang, J.C.3
  • 55
    • 0030962059 scopus 로고    scopus 로고
    • Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
    • Ikeda H, Lethe B, Lehmann F, et al. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 1997;6(2):199-208.
    • (1997) Immunity , vol.6 , Issue.2 , pp. 199-208
    • Ikeda, H.1    Lethe, B.2    Lehmann, F.3
  • 56
    • 0030800823 scopus 로고    scopus 로고
    • A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma
    • Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med. 1997;186(5):785-793.
    • (1997) J Exp Med , vol.186 , Issue.5 , pp. 785-793
    • Mandruzzato, S.1    Brasseur, F.2    Andry, G.3    Boon, T.4    Van Der Bruggen, P.5
  • 57
    • 0028978274 scopus 로고
    • A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
    • Wolfel T, Hauer M, Schneider J, et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 1995;269(5228):1281-1284.
    • (1995) Science , vol.269 , Issue.5228 , pp. 1281-1284
    • Wolfel, T.1    Hauer, M.2    Schneider, J.3
  • 58
    • 0029669950 scopus 로고    scopus 로고
    • A mutated b-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
    • Robbins PF, El-Gamil M, Li YF, et al. A mutated b-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J.Exp.Med. 1996;183:1185-1192.
    • (1996) J.Exp.Med , vol.183 , pp. 1185-1192
    • Robbins, P.F.1    El-Gamil, M.2    Li, Y.F.3
  • 59
    • 0030900696 scopus 로고    scopus 로고
    • Stabilization of beta-catenin by genetic defects in melanoma cell lines [see comments]
    • Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines [see comments]. Science. 1997;275(5307):1790-1792.
    • (1997) Science , vol.275 , Issue.5307 , pp. 1790-1792
    • Rubinfeld, B.1    Robbins, P.2    El-Gamil, M.3    Albert, I.4    Porfiri, E.5    Polakis, P.6
  • 60
    • 2442467847 scopus 로고    scopus 로고
    • T Cells Associated with Tumor Regression Recognize Frameshifted Products of the CDKN2A Tumor Suppressor Gene Locus and a Mutated HLA Class i Gene Product
    • May 15
    • Huang J, El-Gamil M, Dudley ME, Li YF, Rosenberg SA, Robbins PF. T Cells Associated with Tumor Regression Recognize Frameshifted Products of the CDKN2A Tumor Suppressor Gene Locus and a Mutated HLA Class I Gene Product. J Immunol. May 15 2004;172(10):6057-6064.
    • (2004) J Immunol , vol.172 , Issue.10 , pp. 6057-6064
    • Huang, J.1    El-Gamil, M.2    Dudley, M.E.3    Li, Y.F.4    Rosenberg, S.A.5    Robbins, P.F.6
  • 61
    • 0028998866 scopus 로고
    • Mutations associated with familial melanoma impair p16INK4 function
    • Ranade K, Hussussian CJ, Sikorski RS, et al. Mutations associated with familial melanoma impair p16INK4 function. Nat Genet. 1995;10(1):114-116.
    • (1995) Nat Genet , vol.10 , Issue.1 , pp. 114-116
    • Ranade, K.1    Hussussian, C.J.2    Sikorski, R.S.3
  • 62
    • 0033992481 scopus 로고    scopus 로고
    • The Yin-Yang of TCF/beta-catenin signaling
    • Barker N, Morin PJ, Clevers H. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res. 2000;77:1-24.
    • (2000) Adv Cancer Res , vol.77 , pp. 1-24
    • Barker, N.1    Morin, P.J.2    Clevers, H.3
  • 63
    • 0030749292 scopus 로고    scopus 로고
    • Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation
    • Gjertsen MK, Bjorheim J, Saeterdal I, Myklebust J, Gaudernack G. Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. Int J Cancer. 1997;72(5):784-790.
    • (1997) Int J Cancer , vol.72 , Issue.5 , pp. 784-790
    • Gjertsen, M.K.1    Bjorheim, J.2    Saeterdal, I.3    Myklebust, J.4    Gaudernack, G.5
  • 64
    • 0036569985 scopus 로고    scopus 로고
    • A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion
    • May 1
    • Linard B, Bezieau S, Benlalam H, et al. A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion. J Immunol. May 1 2002;168(9):4802- 4808.
    • (2002) J Immunol , vol.168 , Issue.9 , pp. 4802-4808
    • Linard, B.1    Bezieau, S.2    Benlalam, H.3
  • 65
    • 0021802841 scopus 로고
    • Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
    • Jun 13-19
    • Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. Jun 13-19 1985;315(6020):550-554.
    • (1985) Nature , vol.315 , Issue.6020 , pp. 550-554
    • Shtivelman, E.1    Lifshitz, B.2    Gale, R.P.3    Canaani, E.4
  • 66
    • 0032523810 scopus 로고    scopus 로고
    • Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia
    • May 15
    • Yotnda P, Firat H, Garcia-Pons F, et al. Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. J Clin Invest. May 15 1998;101(10):2290-2296.
    • (1998) J Clin Invest , vol.101 , Issue.10 , pp. 2290-2296
    • Yotnda, P.1    Firat, H.2    Garcia-Pons, F.3
  • 67
    • 0034662263 scopus 로고    scopus 로고
    • Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules
    • Zeng G, Touloukian CE, Wang X, Restifo NP, Rosenberg SA, Wang RF. Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules. J Immunol. 2000;165(2):1153-1159.
    • (2000) J Immunol , vol.165 , Issue.2 , pp. 1153-1159
    • Zeng, G.1    Touloukian, C.E.2    Wang, X.3    Restifo, N.P.4    Rosenberg, S.A.5    Wang, R.F.6
  • 68
    • 0034282998 scopus 로고    scopus 로고
    • NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells
    • Zarour HM, Storkus WJ, Brusic V, Williams E, Kirkwood JM. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. Cancer Res. 2000;60(17):4946-4952.
    • (2000) Cancer Res , vol.60 , Issue.17 , pp. 4946-4952
    • Zarour, H.M.1    Storkus, W.J.2    Brusic, V.3    Williams, E.4    Kirkwood, J.M.5
  • 69
    • 0036141435 scopus 로고    scopus 로고
    • NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1-and Th2-type tumor-reactive CD4+ T cells
    • Jan 1
    • Zarour HM, Maillere B, Brusic V, et al. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1-and Th2-type tumor-reactive CD4+ T cells. Cancer Res. Jan 1 2002;62(1):213-218.
    • (2002) Cancer Res , vol.62 , Issue.1 , pp. 213-218
    • Zarour, H.M.1    Maillere, B.2    Brusic, V.3
  • 70
    • 0035957422 scopus 로고    scopus 로고
    • CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production
    • Zeng G, Wang X, Robbins PF, Rosenberg SA, Wang RF. CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production. Proc Natl Acad Sci USA. 2001;98(7):3964-3969.
    • (2001) Proc Natl Acad Sci USA , vol.98 , Issue.7 , pp. 3964-3969
    • Zeng, G.1    Wang, X.2    Robbins, P.F.3    Rosenberg, S.A.4    Wang, R.F.5
  • 71
    • 0041305899 scopus 로고    scopus 로고
    • Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses
    • Jul 22
    • Gnjatic S, Atanackovic D, Jager E, et al. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proc Natl Acad Sci USA. Jul 22 2003;100(15):8862-8867.
    • (2003) Proc Natl Acad Sci USA , vol.100 , Issue.15 , pp. 8862-8867
    • Gnjatic, S.1    Atanackovic, D.2    Jager, E.3
  • 73
    • 0033103512 scopus 로고    scopus 로고
    • Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes [see comments]
    • Chaux P, Vantomme V, Stroobant V, et al. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes [see comments]. J Exp Med. 1999;189(5):767-778.
    • (1999) J Exp Med , vol.189 , Issue.5 , pp. 767-778
    • Chaux, P.1    Vantomme, V.2    Stroobant, V.3
  • 74
    • 0034176020 scopus 로고    scopus 로고
    • Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice
    • Touloukian CE, Leitner WW, Topalian SL, et al. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice. J Immunol. 2000;164(7):3535-3542.
    • (2000) J Immunol , vol.164 , Issue.7 , pp. 3535-3542
    • Touloukian, C.E.1    Leitner, W.W.2    Topalian, S.L.3
  • 75
    • 0035887664 scopus 로고    scopus 로고
    • Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class i and class II epitopes from the melanoma antigen glycoprotein 100
    • Oct 15
    • Lapointe R, Royal RE, Reeves ME, Altomare I, Robbins PF, Hwu P. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100. J Immunol. Oct 15 2001;167(8):4758-4764.
    • (2001) J Immunol , vol.167 , Issue.8 , pp. 4758-4764
    • Lapointe, R.1    Royal, R.E.2    Reeves, M.E.3    Altomare, I.4    Robbins, P.F.5    Hwu, P.6
  • 76
    • 1442336045 scopus 로고    scopus 로고
    • Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein
    • Mar-Apr
    • Parkhurst MR, Riley JP, Robbins PF, Rosenberg SA. Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein. J Immunother. Mar-Apr 2004;27(2):79-91.
    • (2004) J Immunother , vol.27 , Issue.2 , pp. 79-91
    • Parkhurst, M.R.1    Riley, J.P.2    Robbins, P.F.3    Rosenberg, S.A.4
  • 77
    • 0029979997 scopus 로고    scopus 로고
    • Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes
    • Topalian SL, Gonzales MI, Parkhurst M, et al. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J.Exp.Med. 1996;183:1965-1971.
    • (1996) J.Exp.Med , vol.183 , pp. 1965-1971
    • Topalian, S.L.1    Gonzales, M.I.2    Parkhurst, M.3
  • 78
    • 0037111530 scopus 로고    scopus 로고
    • Multiple HLA Class II-Restricted Melanocyte Differentiation Antigens Are Recognized by Tumor-Infiltrating Lymphocytes from a Patient with Melanoma
    • Nov 15
    • Robbins PF, El-Gamil M, Li YF, Zeng G, Dudley M, Rosenberg SA. Multiple HLA Class II-Restricted Melanocyte Differentiation Antigens Are Recognized by Tumor-Infiltrating Lymphocytes from a Patient with Melanoma. J Immunol. Nov 15 2002;169(10):6036-6047.
    • (2002) J Immunol , vol.169 , Issue.10 , pp. 6036-6047
    • Robbins, P.F.1    El-Gamil, M.2    Li, Y.F.3    Zeng, G.4    Dudley, M.5    Rosenberg, S.A.6
  • 79
    • 0038618831 scopus 로고    scopus 로고
    • Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen
    • Jun 15
    • Novellino L, Renkvist N, Rini F, et al. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen. J Immunol. Jun 15 2003;170(12):6363-6370.
    • (2003) J Immunol , vol.170 , Issue.12 , pp. 6363-6370
    • Novellino, L.1    Renkvist, N.2    Rini, F.3
  • 80
    • 0029967001 scopus 로고    scopus 로고
    • Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide
    • Bosch GJ, Joosten AM, Kessler JH, Melief CJ, Leeksma OC. Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Blood. 1996;88(9):3522-3527.
    • (1996) Blood , vol.88 , Issue.9 , pp. 3522-3527
    • Bosch, G.J.1    Joosten, A.M.2    Kessler, J.H.3    Melief, C.J.4    Leeksma, O.C.5
  • 81
    • 0031183901 scopus 로고    scopus 로고
    • The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes
    • Robbins PF, El-Gamil M, Li YF, Fitzgerald EB, Kawakami Y, Rosenberg SA. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J Immunol. 1997;159(1):303-308.
    • (1997) J Immunol , vol.159 , Issue.1 , pp. 303-308
    • Robbins, P.F.1    El-Gamil, M.2    Li, Y.F.3    Fitzgerald, E.B.4    Kawakami, Y.5    Rosenberg, S.A.6
  • 82
    • 0036498599 scopus 로고    scopus 로고
    • Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy
    • Rosenberg SA, Tong-On P, Li Y, et al. Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy. J Immunol. 2002;168(5):2402-2407.
    • (2002) J Immunol , vol.168 , Issue.5 , pp. 2402-2407
    • Rosenberg, S.A.1    Tong-On, P.2    Li, Y.3
  • 84
    • 0032517341 scopus 로고    scopus 로고
    • The p16INK4a/CDKN2A tumor suppressor and its relatives
    • Oct 14
    • Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta. Oct 14 1998;1378(2):F115-177.
    • (1998) Biochim Biophys Acta , vol.1378 , Issue.2
    • Ruas, M.1    Peters, G.2
  • 85
    • 0029781734 scopus 로고    scopus 로고
    • The proteolytic fragments generated by vertebrate proteasomes: Structural relationships to major histocompatibility complex class i binding peptides
    • Niedermann G, King G, Butz S, et al. The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides. Proc Natl Acad Sci USA. 1996;93(16):8572-8577.
    • (1996) Proc Natl Acad Sci USA , vol.93 , Issue.16 , pp. 8572-8577
    • Niedermann, G.1    King, G.2    Butz, S.3
  • 86
    • 0034643336 scopus 로고    scopus 로고
    • Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
    • Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 2000;404(6779):770-774.
    • (2000) Nature , vol.404 , Issue.6779 , pp. 770-774
    • Schubert, U.1    Anton, L.C.2    Gibbs, J.3    Norbury, C.C.4    Yewdell, J.W.5    Bennink, J.R.6
  • 87
    • 0031568653 scopus 로고    scopus 로고
    • MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL
    • Feb 15
    • Deng Y, Yewdell JW, Eisenlohr LC, Bennink JR. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J Immunol. Feb 15 1997;158(4):1507-1515.
    • (1997) J Immunol , vol.158 , Issue.4 , pp. 1507-1515
    • Deng, Y.1    Yewdell, J.W.2    Eisenlohr, L.C.3    Bennink, J.R.4
  • 88
    • 0033046472 scopus 로고    scopus 로고
    • Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
    • Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol. 1999;17:51-88.
    • (1999) Annu Rev Immunol , vol.17 , pp. 51-88
    • Yewdell, J.W.1    Bennink, J.R.2
  • 89
    • 0034192348 scopus 로고    scopus 로고
    • A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma
    • Moreau-Aubry A, Le Guiner S, Labarriere N, Gesnel MC, Jotereau F, Breathnach R. A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma. J Exp Med. 2000;191(9):1617-1624.
    • (2000) J Exp Med , vol.191 , Issue.9 , pp. 1617-1624
    • Moreau-Aubry, A.1    Le Guiner, S.2    Labarriere, N.3    Gesnel, M.C.4    Jotereau, F.5    Breathnach, R.6
  • 90
    • 0034839946 scopus 로고    scopus 로고
    • Melanoma-Reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor types
    • Harada M, Li YF, El-Gamil M, Ohnmacht GA, Rosenberg SA, Robbins PF. Melanoma-Reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor types. J Immunother. 2001;24(4):323-333.
    • (2001) J Immunother , vol.24 , Issue.4 , pp. 323-333
    • Harada, M.1    Li, Y.F.2    El-Gamil, M.3    Ohnmacht, G.A.4    Rosenberg, S.A.5    Robbins, P.F.6
  • 91
    • 0033151591 scopus 로고    scopus 로고
    • The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
    • Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity. 1999;10(6):673-679.
    • (1999) Immunity , vol.10 , Issue.6 , pp. 673-679
    • Vonderheide, R.H.1    Hahn, W.C.2    Schultze, J.L.3    Nadler, L.M.4
  • 92
    • 0035182192 scopus 로고    scopus 로고
    • Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis
    • Kessler JH, Beekman NJ, Bres-Vloemans SA, et al. Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J Exp Med. 2001;193(1):73-88.
    • (2001) J Exp Med , vol.193 , Issue.1 , pp. 73-88
    • Kessler, J.H.1    Beekman, N.J.2    Bres-Vloemans, S.A.3
  • 93
    • 0033980648 scopus 로고    scopus 로고
    • Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
    • Morel S, Levy F, Burlet-Schiltz O, et al. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity. 2000;12(1):107-117.
    • (2000) Immunity , vol.12 , Issue.1 , pp. 107-117
    • Morel, S.1    Levy, F.2    Burlet-Schiltz, O.3
  • 94
    • 0037128172 scopus 로고    scopus 로고
    • The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome
    • Feb 18
    • Schultz ES, Chapiro J, Lurquin C, et al. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J Exp Med. Feb 18 2002;195(4):391-399.
    • (2002) J Exp Med , vol.195 , Issue.4 , pp. 391-399
    • Schultz, E.S.1    Chapiro, J.2    Lurquin, C.3
  • 95
    • 0036791206 scopus 로고    scopus 로고
    • Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzyme
    • Oct 1
    • Topalian SL, Gonzales MI, Ward Y, Wang X, Wang RF. Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzyme. Cancer Res. Oct 1 2002;62(19):5505-5509.
    • (2002) Cancer Res , vol.62 , Issue.19 , pp. 5505-5509
    • Topalian, S.L.1    Gonzales, M.I.2    Ward, Y.3    Wang, X.4    Wang, R.F.5
  • 96
    • 0027259262 scopus 로고
    • Identification of peptide:N-glycanase activity in mammalian-derived cultured cells
    • Suzuki T, Seko A, Kitajima K, Inoue Y, Inoue S. Identification of peptide:N-glycanase activity in mammalian-derived cultured cells. Biochem Biophys Res Commun. 1993;194(3):1124-1130.
    • (1993) Biochem Biophys Res Commun , vol.194 , Issue.3 , pp. 1124-1130
    • Suzuki, T.1    Seko, A.2    Kitajima, K.3    Inoue, Y.4    Inoue, S.5
  • 97
    • 0031973735 scopus 로고    scopus 로고
    • The class i antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol
    • Mosse CA, Meadows L, Luckey CJ, et al. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J Exp Med. 1998;187(1):37-48.
    • (1998) J Exp Med , vol.187 , Issue.1 , pp. 37-48
    • Mosse, C.A.1    Meadows, L.2    Luckey, C.J.3
  • 98
    • 0034599497 scopus 로고    scopus 로고
    • Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy
    • Colella TA, Bullock TN, Russell LB, et al. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy. J Exp Med. 2000;191(7):1221-1232.
    • (2000) J Exp Med , vol.191 , Issue.7 , pp. 1221-1232
    • Colella, T.A.1    Bullock, T.N.2    Russell, L.B.3
  • 99
    • 0037174674 scopus 로고    scopus 로고
    • Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
    • Oct 25
    • Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes. Science. Oct 25 2002;298(5594):850-854.
    • (2002) Science , vol.298 , Issue.5594 , pp. 850-854
    • Dudley, M.E.1    Wunderlich, J.R.2    Robbins, P.F.3
  • 100
    • 0028952240 scopus 로고
    • BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
    • Boel P, Wildmann C, Sensi ML, et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 1995;2(2):167-175.
    • (1995) Immunity , vol.2 , Issue.2 , pp. 167-175
    • Boel, P.1    Wildmann, C.2    Sensi, M.L.3
  • 101
    • 0032528174 scopus 로고    scopus 로고
    • The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes
    • Fleischhauer K, Gattinoni L, Dalerba P, et al. The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes. Cancer Res. 1998;58(14):2969- 2972.
    • (1998) Cancer Res , vol.58 , Issue.14 , pp. 2969-2972
    • Fleischhauer, K.1    Gattinoni, L.2    Dalerba, P.3
  • 102
    • 0029085917 scopus 로고
    • A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
    • Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med. 1995;182(3):689-698.
    • (1995) J Exp Med , vol.182 , Issue.3 , pp. 689-698
    • Van Den Eynde, B.1    Peeters, O.2    De Backer, O.3    Gaugler, B.4    Lucas, S.5    Boon, T.6
  • 103
    • 15844363121 scopus 로고    scopus 로고
    • A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase v gene
    • Guilloux Y, Lucas S, Brichard VG, et al. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J Exp Med. 1996;183(3):1173-1183.
    • (1996) J Exp Med , vol.183 , Issue.3 , pp. 1173-1183
    • Guilloux, Y.1    Lucas, S.2    Brichard, V.G.3
  • 104
    • 0033010380 scopus 로고    scopus 로고
    • Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1
    • Aarnoudse CA, van den Doel PB, Heemskerk B, Schrier PI. Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1. Int J Cancer. 1999;82(3):442-448.
    • (1999) Int J Cancer , vol.82 , Issue.3 , pp. 442-448
    • Aarnoudse, C.A.1    Van Den Doel, P.B.2    Heemskerk, B.3    Schrier, P.I.4
  • 105
    • 0026645959 scopus 로고
    • A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E
    • Traversari C, van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med. 1992;176(5):1453-1457.
    • (1992) J Exp Med , vol.176 , Issue.5 , pp. 1453-1457
    • Traversari, C.1    Van Der Bruggen, P.2    Luescher, I.F.3
  • 106
    • 0033198114 scopus 로고    scopus 로고
    • Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1
    • Chaux P, Luiten R, Demotte N, et al. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J Immunol. 1999;163(5):2928-2936.
    • (1999) J Immunol , vol.163 , Issue.5 , pp. 2928-2936
    • Chaux, P.1    Luiten, R.2    Demotte, N.3
  • 107
    • 0032838012 scopus 로고    scopus 로고
    • Generation of specific antitumor reactivity by the stimulation of spleen cells from gastric cancer patients with MAGE-3 synthetic peptide
    • Fujie T, Tanaka F, Tahara K, et al. Generation of specific antitumor reactivity by the stimulation of spleen cells from gastric cancer patients with MAGE-3 synthetic peptide. Cancer Immunol Immunother. 1999;48(4):189-194.
    • (1999) Cancer Immunol Immunother , vol.48 , Issue.4 , pp. 189-194
    • Fujie, T.1    Tanaka, F.2    Tahara, K.3
  • 108
    • 0033151628 scopus 로고    scopus 로고
    • Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family
    • Jun 1
    • Tanzarella S, Russo V, Lionello I, et al. Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family. Cancer Res. Jun 1 1999;59(11):2668-2674.
    • (1999) Cancer Res , vol.59 , Issue.11 , pp. 2668-2674
    • Tanzarella, S.1    Russo, V.2    Lionello, I.3
  • 109
    • 0027994050 scopus 로고
    • Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601
    • van der Bruggen P, Szikora JP, Boel P, et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur J Immunol. 1994;24(9):2134-2140.
    • (1994) Eur J Immunol , vol.24 , Issue.9 , pp. 2134-2140
    • Van Der Bruggen, P.1    Szikora, J.P.2    Boel, P.3
  • 110
    • 0030611816 scopus 로고    scopus 로고
    • Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product
    • Visseren MJ, van der Burg SH, van der Voort EI, et al. Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product. Int J Cancer. 1997;73(1):125-130.
    • (1997) Int J Cancer , vol.73 , Issue.1 , pp. 125-130
    • Visseren, M.J.1    Van Der Burg, S.H.2    Van Der Voort, E.I.3
  • 111
    • 0032792104 scopus 로고    scopus 로고
    • Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes [In Process Citation]
    • Tahara K, Takesako K, Sette A, Celis E, Kitano S, Akiyoshi T. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes [In Process Citation]. Clin Cancer Res. 1999;5(8):2236-2241.
    • (1999) Clin Cancer Res , vol.5 , Issue.8 , pp. 2236-2241
    • Tahara, K.1    Takesako, K.2    Sette, A.3    Celis, E.4    Kitano, S.5    Akiyoshi, T.6
  • 112
    • 0030871041 scopus 로고    scopus 로고
    • Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24
    • Tanaka F, Fujie T, Tahara K, et al. Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24. Cancer Res. 1997;57(20):4465-4468.
    • (1997) Cancer Res , vol.57 , Issue.20 , pp. 4465-4468
    • Tanaka, F.1    Fujie, T.2    Tahara, K.3
  • 113
    • 0032912207 scopus 로고    scopus 로고
    • A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes
    • Oiso M, Eura M, Katsura F, et al. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes. Int J Cancer. 1999;81(3):387-394.
    • (1999) Int J Cancer , vol.81 , Issue.3 , pp. 387-394
    • Oiso, M.1    Eura, M.2    Katsura, F.3
  • 114
    • 18644381320 scopus 로고    scopus 로고
    • A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18
    • Jul
    • Bilsborough J, Panichelli C, Duffour MT, et al. A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18. Tissue Antigens. Jul 2002;60(1):16-24.
    • (2002) Tissue Antigens , vol.60 , Issue.1 , pp. 16-24
    • Bilsborough, J.1    Panichelli, C.2    Duffour, M.T.3
  • 115
    • 0035084353 scopus 로고    scopus 로고
    • A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes
    • Schultz ES, Zhang Y, Knowles R, et al. A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes. Tissue Antigens. 2001;57(2):103-109.
    • (2001) Tissue Antigens , vol.57 , Issue.2 , pp. 103-109
    • Schultz, E.S.1    Zhang, Y.2    Knowles, R.3
  • 116
    • 0029875680 scopus 로고    scopus 로고
    • A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3
    • Herman J, van der Bruggen P, Luescher IF, et al. A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics. 1996;43(6):377-383.
    • (1996) Immunogenetics , vol.43 , Issue.6 , pp. 377-383
    • Herman, J.1    Van Der Bruggen, P.2    Luescher, I.F.3
  • 117
    • 0242301671 scopus 로고    scopus 로고
    • New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells
    • Nov
    • Kobayashi T, Lonchay C, Colau D, Demotte N, Boon T, van der Bruggen P. New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells. Tissue Antigens. Nov 2003;62(5):426-432.
    • (2003) Tissue Antigens , vol.62 , Issue.5 , pp. 426-432
    • Kobayashi, T.1    Lonchay, C.2    Colau, D.3    Demotte, N.4    Boon, T.5    Van Der Bruggen, P.6
  • 119
    • 0036866064 scopus 로고    scopus 로고
    • A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes
    • Nov
    • Zhang Y, Stroobant V, Russo V, Boon T, van der Bruggen P. A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes. Tissue Antigens. Nov 2002;60(5):365-371.
    • (2002) Tissue Antigens , vol.60 , Issue.5 , pp. 365-371
    • Zhang, Y.1    Stroobant, V.2    Russo, V.3    Boon, T.4    Van Der Bruggen, P.5
  • 120
    • 0032993152 scopus 로고    scopus 로고
    • A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion
    • Zorn E, Hercend T. A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion. Eur J Immunol. 1999;29(2):602-607.
    • (1999) Eur J Immunol , vol.29 , Issue.2 , pp. 602-607
    • Zorn, E.1    Hercend, T.2
  • 121
    • 0033151926 scopus 로고    scopus 로고
    • Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma
    • Huang LQ, Brasseur F, Serrano A, et al. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma. J Immunol. 1999;162(11):6849-6854.
    • (1999) J Immunol , vol.162 , Issue.11 , pp. 6849-6854
    • Huang, L.Q.1    Brasseur, F.2    Serrano, A.3
  • 122
    • 0034655180 scopus 로고    scopus 로고
    • A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12
    • Panelli MC, Bettinotti MP, Lally K, et al. A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12. J Immunol. 2000;164(8):4382-4392.
    • (2000) J Immunol , vol.164 , Issue.8 , pp. 4382-4392
    • Panelli, M.C.1    Bettinotti, M.P.2    Lally, K.3
  • 123
    • 0036132044 scopus 로고    scopus 로고
    • Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue
    • Maeurer MJ, Necker A, Salter RD, et al. Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue. Int J Cancer. 2002;97(1):64-71.
    • (2002) Int J Cancer , vol.97 , Issue.1 , pp. 64-71
    • Maeurer, M.J.1    Necker, A.2    Salter, R.D.3
  • 124
    • 12944265542 scopus 로고    scopus 로고
    • Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class i allele
    • Gnjatic S, Nagata Y, Jager E, et al. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci USA. 2000;97(20):10917-10922.
    • (2000) Proc Natl Acad Sci USA , vol.97 , Issue.20 , pp. 10917-10922
    • Gnjatic, S.1    Nagata, Y.2    Jager, E.3
  • 125
    • 0035110963 scopus 로고    scopus 로고
    • Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells
    • Harada M, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells. Cancer Res. 2001;61(3):1089-1094.
    • (2001) Cancer Res , vol.61 , Issue.3 , pp. 1089-1094
    • Harada, M.1    Li, Y.F.2    El-Gamil, M.3    Rosenberg, S.A.4    Robbins, P.F.5
  • 126
    • 0029042336 scopus 로고
    • Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine [see comments]
    • Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine [see comments]. J Natl Cancer Inst. 1995;87(13):982-990.
    • (1995) J Natl Cancer Inst , vol.87 , Issue.13 , pp. 982-990
    • Tsang, K.Y.1    Zaremba, S.2    Nieroda, C.A.3    Zhu, M.Z.4    Hamilton, J.M.5    Schlom, J.6
  • 127
    • 0033556012 scopus 로고    scopus 로고
    • Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells
    • Jan 15
    • Kawashima I, Tsai V, Southwood S, Takesako K, Sette A, Celis E. Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells. Cancer Res. Jan 15 1999;59(2):431-435.
    • (1999) Cancer Res , vol.59 , Issue.2 , pp. 431-435
    • Kawashima, I.1    Tsai, V.2    Southwood, S.3    Takesako, K.4    Sette, A.5    Celis, E.6
  • 128
    • 14844341146 scopus 로고
    • Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression
    • Kawakami Y, Eliyahu S, Jennings C, et al. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol. 1995;154(8):3961-3968.
    • (1995) J Immunol , vol.154 , Issue.8 , pp. 3961-3968
    • Kawakami, Y.1    Eliyahu, S.2    Jennings, C.3
  • 129
    • 0031568658 scopus 로고    scopus 로고
    • Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells
    • Tsai V, Southwood S, Sidney J, et al. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J Immunol. 1997;158(4):1796-1802.
    • (1997) J Immunol , vol.158 , Issue.4 , pp. 1796-1802
    • Tsai, V.1    Southwood, S.2    Sidney, J.3
  • 130
    • 0032534587 scopus 로고    scopus 로고
    • Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1,-A2, and-A3 alleles
    • Kawakami Y, Robbins PF, Wang X, et al. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1,-A2, and-A3 alleles. J Immunol. 1998;161(12):6985-6992.
    • (1998) J Immunol , vol.161 , Issue.12 , pp. 6985-6992
    • Kawakami, Y.1    Robbins, P.F.2    Wang, X.3
  • 131
    • 0030471145 scopus 로고    scopus 로고
    • Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100
    • Skipper JC, Kittlesen DJ, Hendrickson RC, et al. Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. J Immunol. 1996;157(11):5027-5033.
    • (1996) J Immunol , vol.157 , Issue.11 , pp. 5027-5033
    • Skipper, J.C.1    Kittlesen, D.J.2    Hendrickson, R.C.3
  • 132
    • 0036024178 scopus 로고    scopus 로고
    • Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clones
    • Apr
    • Sensi M, Pellegatta S, Vegetti C, Nicolini G, Parmiani G, Anichini A. Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clones. Tissue Antigens. Apr 2002;59(4):273-279.
    • (2002) Tissue Antigens , vol.59 , Issue.4 , pp. 273-279
    • Sensi, M.1    Pellegatta, S.2    Vegetti, C.3    Nicolini, G.4    Parmiani, G.5    Anichini, A.6
  • 133
    • 0037058679 scopus 로고    scopus 로고
    • Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer
    • Dec 10
    • Jaramillo A, Majumder K, Manna PP, et al. Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer. Int J Cancer. Dec 10 2002;102(5):499-506.
    • (2002) Int J Cancer , vol.102 , Issue.5 , pp. 499-506
    • Jaramillo, A.1    Majumder, K.2    Manna, P.P.3
  • 134
    • 0028302028 scopus 로고
    • Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes
    • Kawakami Y, Eliyahu S, Sakaguchi K, et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J.Exp.Med. 1994;180:347-352.
    • (1994) J.Exp.Med , vol.180 , pp. 347-352
    • Kawakami, Y.1    Eliyahu, S.2    Sakaguchi, K.3
  • 135
    • 0028919215 scopus 로고
    • Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes
    • Castelli C, Storkus WJ, Maeurer MJ, et al. Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. J Exp Med. 1995;181(1):363-368.
    • (1995) J Exp Med , vol.181 , Issue.1 , pp. 363-368
    • Castelli, C.1    Storkus, W.J.2    Maeurer, M.J.3
  • 136
    • 0030804305 scopus 로고    scopus 로고
    • Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells
    • Salazar-Onfray F, Nakazawa T, Chhajlani V, et al. Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells. Cancer Res. 1997;57(19):4348-4355.
    • (1997) Cancer Res , vol.57 , Issue.19 , pp. 4348-4355
    • Salazar-Onfray, F.1    Nakazawa, T.2    Chhajlani, V.3
  • 138
    • 0029818386 scopus 로고    scopus 로고
    • A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma
    • Gaugler B, Brouwenstijn N, Vantomme V, et al. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics. 1996;44(5):323-330.
    • (1996) Immunogenetics , vol.44 , Issue.5 , pp. 323-330
    • Gaugler, B.1    Brouwenstijn, N.2    Vantomme, V.3
  • 139
    • 0036605973 scopus 로고    scopus 로고
    • The Waardenburg Syndrome Type 4 Gene, SOX10, is a Novel Tumor-associated Antigen Identified in a Patient with a Dramatic Response to Immunotherapy
    • Khong HT, Rosenberg SA. The Waardenburg Syndrome Type 4 Gene, SOX10, Is a Novel Tumor-associated Antigen Identified in a Patient with a Dramatic Response to Immunotherapy. Cancer Res. 2002;62(11):3020-3023.
    • (2002) Cancer Res , vol.62 , Issue.11 , pp. 3020-3023
    • Khong, H.T.1    Rosenberg, S.A.2
  • 140
    • 0032212445 scopus 로고    scopus 로고
    • Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2)
    • Parkhurst MR, Fitzgerald EB, Southwood S, Sette A, Rosenberg SA, Kawakami Y. Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). Cancer Res. 1998;58(21):4895-4901.
    • (1998) Cancer Res , vol.58 , Issue.21 , pp. 4895-4901
    • Parkhurst, M.R.1    Fitzgerald, E.B.2    Southwood, S.3    Sette, A.4    Rosenberg, S.A.5    Kawakami, Y.6
  • 141
    • 0342647351 scopus 로고    scopus 로고
    • Naturally processed and concealed HLA-A2.1-restricted epitopes from tumor-associated antigen tyrosinase-related protein-2
    • Jul 15
    • Noppen C, Levy F, Burri L, et al. Naturally processed and concealed HLA-A2.1-restricted epitopes from tumor-associated antigen tyrosinase-related protein-2. Int J Cancer. Jul 15 2000;87(2):241-246.
    • (2000) Int J Cancer , vol.87 , Issue.2 , pp. 241-246
    • Noppen, C.1    Levy, F.2    Burri, L.3
  • 142
    • 0031974725 scopus 로고    scopus 로고
    • Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and-A33
    • Wang RF, Johnston, S.L., Southwood, S., Sette, A., and Rosenberg, S.A. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and-A33. J. Immunol. 1998;160:890-897.
    • (1998) J. Immunol , vol.160 , pp. 890-897
    • Wang, R.F.1    Johnston, S.L.2    Southwood, S.3    Sette, A.4    Rosenberg, S.A.5
  • 143
    • 0034255894 scopus 로고    scopus 로고
    • Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen
    • Sun Y, Song M, Stevanovic S, et al. Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen. Int J Cancer. 2000;87(3):399-404.
    • (2000) Int J Cancer , vol.87 , Issue.3 , pp. 399-404
    • Sun, Y.1    Song, M.2    Stevanovic, S.3
  • 144
    • 0032030641 scopus 로고    scopus 로고
    • Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development
    • Kittlesen DJ, Thompson LW, Gulden PH, et al. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. J Immunol. 1998;160(5):2099-2106.
    • (1998) J Immunol , vol.160 , Issue.5 , pp. 2099-2106
    • Kittlesen, D.J.1    Thompson, L.W.2    Gulden, P.H.3
  • 145
    • 0029094922 scopus 로고
    • Identification of a tyrosinase epitope reocognized by HLA-A24 restricted tumor-infiltrating lymphocytes
    • Kang X-Q, Kawakami Y, Sakaguchi K, et al. Identification of a tyrosinase epitope reocognized by HLA-A24 restricted tumor-infiltrating lymphocytes. J.Immunol. 1995;155:1343-1348.
    • (1995) J.Immunol , vol.155 , pp. 1343-1348
    • Kang, X.-Q.1    Kawakami, Y.2    Sakaguchi, K.3
  • 146
    • 0032710052 scopus 로고    scopus 로고
    • A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes
    • Dec 10
    • Morel S, Ooms A, Van Pel A, et al. A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes. Int J Cancer. Dec 10 1999;83(6):755-759.
    • (1999) Int J Cancer , vol.83 , Issue.6 , pp. 755-759
    • Morel, S.1    Ooms, A.2    Van Pel, A.3
  • 147
    • 0030048081 scopus 로고    scopus 로고
    • A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes
    • Brichard VG, Herman J, Van Pel A, et al. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur J Immunol. 1996;26(1):224-230.
    • (1996) Eur J Immunol , vol.26 , Issue.1 , pp. 224-230
    • Brichard, V.G.1    Herman, J.2    Van Pel, A.3
  • 148
    • 0033168417 scopus 로고    scopus 로고
    • Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein
    • Butterfield LH, Koh A, Meng W, et al. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein. Cancer Res. 1999;59(13):3134-3142.
    • (1999) Cancer Res , vol.59 , Issue.13 , pp. 3134-3142
    • Butterfield, L.H.1    Koh, A.2    Meng, W.3
  • 149
    • 0036801038 scopus 로고    scopus 로고
    • Labeling antigen-specific CD4(+) T cells with class II MHC oligomers
    • Oct 1
    • Cameron TO, Norris PJ, Patel A, et al. Labeling antigen-specific CD4(+) T cells with class II MHC oligomers. J Immunol Methods. Oct 1 2002;268(1):51-69.
    • (2002) J Immunol Methods , vol.268 , Issue.1 , pp. 51-69
    • Cameron, T.O.1    Norris, P.J.2    Patel, A.3
  • 150
    • 0037140934 scopus 로고    scopus 로고
    • Cleavage and polyadenylation specificity factor (CPSF)-derived peptides can induce HLA-A2-restricted and tumor-specific CTLs in the majority of gastrointestinal cancer patients
    • May 20
    • Maeda Y, Ito M, Harashima N, et al. Cleavage and polyadenylation specificity factor (CPSF)-derived peptides can induce HLA-A2-restricted and tumor-specific CTLs in the majority of gastrointestinal cancer patients. Int J Cancer. May 20 2002;99(3):409-417.
    • (2002) Int J Cancer , vol.99 , Issue.3 , pp. 409-417
    • Maeda, Y.1    Ito, M.2    Harashima, N.3
  • 151
    • 0033230634 scopus 로고    scopus 로고
    • The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes
    • Vissers JL, De Vries IJ, Schreurs MW, et al. The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes. Cancer Res. 1999;59(21):5554-5559.
    • (1999) Cancer Res , vol.59 , Issue.21 , pp. 5554-5559
    • Vissers, J.L.1    De Vries, I.J.2    Schreurs, M.W.3
  • 153
    • 0033168153 scopus 로고    scopus 로고
    • A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ
    • Ronsin C, Chung-Scott V, Poullion I, Aknouche N, Gaudin C, Triebel F. A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ. J Immunol. 1999;163(1):483-490.
    • (1999) J Immunol , vol.163 , Issue.1 , pp. 483-490
    • Ronsin, C.1    Chung-Scott, V.2    Poullion, I.3    Aknouche, N.4    Gaudin, C.5    Triebel, F.6
  • 154
    • 0035927041 scopus 로고    scopus 로고
    • An Alternative Open Reading Frame of the Human Macrophage
    • Probst-Kepper M, Stroobant V, Kridel R, et al. An Alternative Open Reading Frame of the Human Macrophage Colony-stimulating Factor Gene Is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-infiltrating CD8 T Lymphocytes. J Exp Med. 2001;193(10):1189-1198.
    • (2001) J Exp Med , vol.193 , Issue.10 , pp. 1189-1198
    • Probst-Kepper, M.1    Stroobant, V.2    Kridel, R.3
  • 155
    • 0033564363 scopus 로고    scopus 로고
    • Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies
    • Brossart P, Heinrich KS, Stuhler G, et al. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood. 1999;93(12):4309-4317.
    • (1999) Blood , vol.93 , Issue.12 , pp. 4309-4317
    • Brossart, P.1    Heinrich, K.S.2    Stuhler, G.3
  • 156
    • 1842339552 scopus 로고    scopus 로고
    • Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide
    • Ropke M, Hald J, Guldberg P, et al. Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc Natl Acad Sci USA. 1996;93(25):14704-14707.
    • (1996) Proc Natl Acad Sci USA , vol.93 , Issue.25 , pp. 14704-14707
    • Ropke, M.1    Hald, J.2    Guldberg, P.3
  • 157
    • 0033965590 scopus 로고    scopus 로고
    • Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells in vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein
    • Feb
    • Barfoed AM, Petersen TR, Kirkin AF, Thor Straten P, Claesson MH, Zeuthen J. Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein. Scand J Immunol. Feb 2000;51(2):128-133.
    • (2000) Scand J Immunol , vol.51 , Issue.2 , pp. 128-133
    • Barfoed, A.M.1    Petersen, T.R.2    Kirkin, A.F.3    Thor Straten, P.4    Claesson, M.H.5    Zeuthen, J.6
  • 158
    • 12944265535 scopus 로고    scopus 로고
    • A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck
    • Eura M, Chikamatsu K, Katsura F, et al. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck. Clin Cancer Res. 2000;6(3):979-986.
    • (2000) Clin Cancer Res , vol.6 , Issue.3 , pp. 979-986
    • Eura, M.1    Chikamatsu, K.2    Katsura, F.3
  • 159
    • 0037442699 scopus 로고    scopus 로고
    • Mutated p53 gene encodes a nonmutated epitope recognized by HLA-B*4601-restricted and tumor cell-reactive CTLs at tumor site
    • Feb 15
    • Azuma K, Shichijo S, Maeda Y, et al. Mutated p53 gene encodes a nonmutated epitope recognized by HLA-B*4601-restricted and tumor cell-reactive CTLs at tumor site. Cancer Res. Feb 15 2003;63(4):854-858.
    • (2003) Cancer Res , vol.63 , Issue.4 , pp. 854-858
    • Azuma, K.1    Shichijo, S.2    Maeda, Y.3
  • 160
    • 0036897522 scopus 로고    scopus 로고
    • Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes
    • Dec
    • Horiguchi Y, Nukaya I, Okazawa K, et al. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes. Clin Cancer Res. Dec 2002;8(12):3885-3892.
    • (2002) Clin Cancer Res , vol.8 , Issue.12 , pp. 3885-3892
    • Horiguchi, Y.1    Nukaya, I.2    Okazawa, K.3
  • 161
    • 0033397770 scopus 로고    scopus 로고
    • A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription
    • Van Den Eynde BJ, Gaugler B, Probst-Kepper M, et al. A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription. J Exp Med. 1999;190(12):1793-1800.
    • (1999) J Exp Med , vol.190 , Issue.12 , pp. 1793-1800
    • Van Den Eynde, B.J.1    Gaugler, B.2    Probst-Kepper, M.3
  • 162
    • 0034282551 scopus 로고    scopus 로고
    • Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides
    • Schmitz M, Diestelkoetter P, Weigle B, et al. Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res. 2000;60(17):4845-4849.
    • (2000) Cancer Res , vol.60 , Issue.17 , pp. 4845-4849
    • Schmitz, M.1    Diestelkoetter, P.2    Weigle, B.3
  • 164
    • 0035872398 scopus 로고    scopus 로고
    • A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma
    • May 15
    • Echchakir H, Mami-Chouaib F, Vergnon I, et al. A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma. Cancer Res. May 15 2001;61(10):4078-4083.
    • (2001) Cancer Res , vol.61 , Issue.10 , pp. 4078-4083
    • Echchakir, H.1    Mami-Chouaib, F.2    Vergnon, I.3
  • 165
    • 0032527907 scopus 로고    scopus 로고
    • Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia
    • Jul 15
    • Yotnda P, Garcia F, Peuchmaur M, et al. Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. J Clin Invest. Jul 15 1998;102(2):455-462.
    • (1998) J Clin Invest , vol.102 , Issue.2 , pp. 455-462
    • Yotnda, P.1    Garcia, F.2    Peuchmaur, M.3
  • 166
    • 0033082486 scopus 로고    scopus 로고
    • A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma
    • Gaudin C, Kremer F, Angevin E, Scott V, Triebel F. A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma. J Immunol. 1999;162(3):1730-1738.
    • (1999) J Immunol , vol.162 , Issue.3 , pp. 1730-1738
    • Gaudin, C.1    Kremer, F.2    Angevin, E.3    Scott, V.4    Triebel, F.5
  • 167
    • 0029939743 scopus 로고    scopus 로고
    • A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma
    • Brandle D, Brasseur F, Weynants P, Boon T, Van den Eynde B. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma. J Exp Med. 1996;183(6):2501-2508.
    • (1996) J Exp Med , vol.183 , Issue.6 , pp. 2501-2508
    • Brandle, D.1    Brasseur, F.2    Weynants, P.3    Boon, T.4    Van Den Eynde, B.5
  • 168
    • 0032526350 scopus 로고    scopus 로고
    • An antigen recognized by autologous CTLs on a human bladder carcinoma
    • Gueguen M, Patard JJ, Gaugler B, et al. An antigen recognized by autologous CTLs on a human bladder carcinoma. J Immunol. 1998;160(12):6188-6194.
    • (1998) J Immunol , vol.160 , Issue.12 , pp. 6188-6194
    • Gueguen, M.1    Patard, J.J.2    Gaugler, B.3
  • 169
    • 0033571145 scopus 로고    scopus 로고
    • Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene
    • Chiari R, Foury F, De Plaen E, Baurain JF, Thonnard J, Coulie PG. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene. Cancer Res. 1999;59(22):5785-5792.
    • (1999) Cancer Res , vol.59 , Issue.22 , pp. 5785-5792
    • Chiari, R.1    Foury, F.2    De Plaen, E.3    Baurain, J.F.4    Thonnard, J.5    Coulie, P.G.6
  • 170
    • 0034090122 scopus 로고    scopus 로고
    • High Frequency of Autologous Anti-Melanoma CTL Directed Against an Antigen Generated by a Point Mutation in a New Helicase Gene
    • Baurain JF, Colau D, van Baren N, et al. High Frequency of Autologous Anti-Melanoma CTL Directed Against an Antigen Generated by a Point Mutation in a New Helicase Gene. J Immunol. 2000;164(11):6057-6066.
    • (2000) J Immunol , vol.164 , Issue.11 , pp. 6057-6066
    • Baurain, J.F.1    Colau, D.2    Van Baren, N.3
  • 171
    • 0033029559 scopus 로고    scopus 로고
    • A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation
    • Zorn E, Hercend T. A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation. Eur J Immunol. 1999;29(2):592-601.
    • (1999) Eur J Immunol , vol.29 , Issue.2 , pp. 592-601
    • Zorn, E.1    Hercend, T.2
  • 172
    • 85044704835 scopus 로고    scopus 로고
    • Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma
    • Jul 19
    • Vigneron N, Ooms A, Morel S, Degiovanni G, Van Den Eynde BJ. Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma. Cancer Immun. Jul 19 2002;2:9.
    • (2002) Cancer Immun , vol.2 , pp. 9
    • Vigneron, N.1    Ooms, A.2    Morel, S.3    Degiovanni, G.4    Van Den Eynde, B.J.5
  • 173
    • 0035865364 scopus 로고    scopus 로고
    • Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes
    • Kawakami Y, Wang X, Shofuda T, et al. Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes. J Immunol. 2001;166(4):2871-2877.
    • (2001) J Immunol , vol.166 , Issue.4 , pp. 2871-2877
    • Kawakami, Y.1    Wang, X.2    Shofuda, T.3
  • 174
    • 0036937082 scopus 로고    scopus 로고
    • Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes
    • Dec
    • Makita M, Azuma T, Hamaguchi H, et al. Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes. Leukemia. Dec 2002;16(12):2400-2407.
    • (2002) Leukemia , vol.16 , Issue.12 , pp. 2400-2407
    • Makita, M.1    Azuma, T.2    Hamaguchi, H.3
  • 175
    • 0033577804 scopus 로고    scopus 로고
    • Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells
    • Wang RF, Wang X, Rosenberg SA. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells. J Exp Med. 1999;189(10):1659-1668.
    • (1999) J Exp Med , vol.189 , Issue.10 , pp. 1659-1668
    • Wang, R.F.1    Wang, X.2    Rosenberg, S.A.3
  • 176
    • 0035818515 scopus 로고    scopus 로고
    • Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
    • Saeterdal I, Bjorheim J, Lislerud K, et al. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA. 2001;98(23):13255-13260.
    • (2001) Proc Natl Acad Sci USA , vol.98 , Issue.23 , pp. 13255-13260
    • Saeterdal, I.1    Bjorheim, J.2    Lislerud, K.3
  • 177
    • 0036793872 scopus 로고    scopus 로고
    • Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen
    • Oct
    • Kobayashi H, Omiya R, Ruiz M, et al. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen. Clin Cancer Res. Oct 2002;8(10):3219-3225.
    • (2002) Clin Cancer Res , vol.8 , Issue.10 , pp. 3219-3225
    • Kobayashi, H.1    Omiya, R.2    Ruiz, M.3
  • 178
    • 0042467770 scopus 로고    scopus 로고
    • NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity
    • Jul
    • Maccalli C, Pende D, Castelli C, Mingari MC, Robbins PF, Parmiani G. NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity. Eur J Immunol. Jul 2003;33(7):2033-2043.
    • (2003) Eur J Immunol , vol.33 , Issue.7 , pp. 2033-2043
    • Maccalli, C.1    Pende, D.2    Castelli, C.3    Mingari, M.C.4    Robbins, P.F.5    Parmiani, G.6
  • 179
    • 0036644723 scopus 로고    scopus 로고
    • Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide-based in vitro stimulation
    • Jul 1
    • Hural JA, Friedman RS, McNabb A, Steen SS, Henderson RA, Kalos M. Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide-based in vitro stimulation. J Immunol. Jul 1 2002;169(1):557-565.
    • (2002) J Immunol , vol.169 , Issue.1 , pp. 557-565
    • Hural, J.A.1    Friedman, R.S.2    McNabb, A.3    Steen, S.S.4    Henderson, R.A.5    Kalos, M.6
  • 180
    • 0034966511 scopus 로고    scopus 로고
    • A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells
    • Jun
    • Chaux P, Lethe B, Van Snick J, et al. A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells. Eur J Immunol. Jun 2001;31(6):1910-1916.
    • (2001) Eur J Immunol , vol.31 , Issue.6 , pp. 1910-1916
    • Chaux, P.1    Lethe, B.2    Van Snick, J.3
  • 181
    • 0037530637 scopus 로고    scopus 로고
    • A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein
    • Jul 1
    • Zhang Y, Chaux P, Stroobant V, et al. A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein. J Immunol. Jul 1 2003;171(1):219-225.
    • (2003) J Immunol , vol.171 , Issue.1 , pp. 219-225
    • Zhang, Y.1    Chaux, P.2    Stroobant, V.3
  • 182
    • 0035874608 scopus 로고    scopus 로고
    • Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles
    • Jun 15
    • Kobayashi H, Song Y, Hoon DS, Appella E, Celis E. Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles. Cancer Res. Jun 15 2001;61(12):4773-4778.
    • (2001) Cancer Res , vol.61 , Issue.12 , pp. 4773-4778
    • Kobayashi, H.1    Song, Y.2    Hoon, D.S.3    Appella, E.4    Celis, E.5
  • 183
    • 0033103192 scopus 로고    scopus 로고
    • Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11 [see comments]
    • Manici S, Sturniolo T, Imro MA, et al. Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11 [see comments]. J Exp Med. 1999;189(5):871-876.
    • (1999) J Exp Med , vol.189 , Issue.5 , pp. 871-876
    • Manici, S.1    Sturniolo, T.2    Imro, M.A.3
  • 184
    • 0037305578 scopus 로고    scopus 로고
    • Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3
    • Feb 1
    • Consogno G, Manici S, Facchinetti V, et al. Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3. Blood. Feb 1 2003;101(3):1038-1044.
    • (2003) Blood , vol.101 , Issue.3 , pp. 1038-1044
    • Consogno, G.1    Manici, S.2    Facchinetti, V.3
  • 185
    • 0033693387 scopus 로고    scopus 로고
    • A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes
    • Schultz ES, Lethe B, Cambiaso CL, et al. A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes. Cancer Res. 2000;60(22):6272-6275.
    • (2000) Cancer Res , vol.60 , Issue.22 , pp. 6272-6275
    • Schultz, E.S.1    Lethe, B.2    Cambiaso, C.L.3
  • 186
    • 0034602674 scopus 로고    scopus 로고
    • Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells
    • Zarour HM, Kirkwood JM, Kierstead LS, et al. Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells. Proc Natl Acad Sci USA. 2000;97(1):400-405.
    • (2000) Proc Natl Acad Sci USA , vol.97 , Issue.1 , pp. 400-405
    • Zarour, H.M.1    Kirkwood, J.M.2    Kierstead, L.S.3
  • 187
    • 0034661697 scopus 로고    scopus 로고
    • Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL
    • Chen JL, Dunbar PR, Gileadi U, et al. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol. 2000;165(2):948-955.
    • (2000) J Immunol , vol.165 , Issue.2 , pp. 948-955
    • Chen, J.L.1    Dunbar, P.R.2    Gileadi, U.3
  • 188
    • 0031974381 scopus 로고    scopus 로고
    • CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase
    • Kobayashi H, Kokubo T, Sato K, et al. CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase. Cancer Res. 1998;58(2):296-301.
    • (1998) Cancer Res , vol.58 , Issue.2 , pp. 296-301
    • Kobayashi, H.1    Kokubo, T.2    Sato, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.